IDEXX Laboratories

IDEXX Laboratories, Inc., together with its subsidiaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, water testing, and dairy markets worldwide. It operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other segments. The company provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assays; veterinary reference laboratory diagnostic and consulting services; practice management systems and services, and digital imaging systems for veterinarians; and biological materials testing and laboratory animal diagnostic instruments and services for biomedical research community. It also offers diagnostic, health-monitoring, and food safety testing products for livestock, poultry, and dairy; products that test water for certain microbiological contaminants; and point-of-care electrolytes and blood gas analyzers that are used in the human point-of-care medical diagnostics market. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers.

Westbrook, US
Size (employees)
7,365 (est)+9%
IDEXX Laboratories was founded in 1983 and is headquartered in Westbrook, US

IDEXX Laboratories Office Locations

IDEXX Laboratories has offices in Westbrook, Saint Petersburg, Sacramento, West Sacramento and in 25 other locations
Westbrook, US (HQ)
1 Idexx Dr

IDEXX Laboratories Metrics

IDEXX Laboratories Financial Metrics

Revenue (2016)

$1.8 b

Revenue growth (2015-16), %


Gross profit

$975.4 m

Gross profit margin (2016), %


Net income (2016)

$222.1 m

Market capitalization (21-Mar-2017)

$13.3 b

Closing share price (21-Mar-2017)


Cash (31-Dec-2016)

$154.9 m
IDEXX Laboratories's current market capitalization is $13.3 b.
IDEXX Laboratories's revenue was reported to be $1.8 b in FY, 2016 which is a 10.8% increase from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016


$1.4 b$1.5 b$1.6 b$1.8 b

Revenue growth, %


Cost of goods sold

$711.6 m$800 m

Gross profit

$756.1 m$816.1 m$890.3 m$975.4 m

Gross profit Margin, %



$266.8 m$260.3 m$299.9 m$350.2 m

EBIT margin, %


Interest income

$2.5 m$3.7 m

Pre tax profit

$273.1 m$321.8 m

Net Income

$187.8 m$182 m$192.1 m$222.1 m
FY, 2013FY, 2014FY, 2015FY, 2016


$279.1 m$322.5 m$129 m$154.9 m

Accounts Receivable


$133.4 m$160.3 m$188.8 m$158 m

Current Assets

$652.7 m$759.4 m$821.6 m$845.6 m


$281.2 m$303.6 m$333 m$357.4 m


$180.5 m$184.5 m$178.9 m$178.2 m

Total Assets

$1.2 b$1.4 b$1.5 b$1.5 b

Accounts Payable

$29.9 m$44.7 m$52.6 m$60.1 m

Total Debt

$151.4 m$351 m

Current Liabilities

$478.4 m$820.9 m$856.8 m$934.6 m

Non-Current Liabilities

$233.9 m$445.7 m$702.2 m$704.3 m

Total Liabilities

$712.3 m$1.3 b$1.6 b$1.6 b

Additional Paid-in Capital

$825.3 m$888.3 m$940.5 m$1 b

Retained Earnings

$1.5 b$1.7 b$318.4 m$540.4 m

Total Equity

$518.2 m$117.6 m($84 m)($108.2 m)

Debt to Equity Ratio

0.3 x3 x

Debt to Assets Ratio

0.1 x0.3 x

Financial Leverage

2.4 x11.8 x-17.6 x-14.1 x
FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

$187.8 m$182 m$192.1 m$222.1 m

Depreciation and Amortization

$54.6 m$58.9 m$69 m$78.2 m

Accounts Receivable

($16 m)($3.6 m)($50 m)($23 m)


($1.3 m)($38 m)($35 m)$7.6 m

Accounts Payable

($4.4 m)$6.7 m($2.5 m)$2.1 m

Cash From Operating Activities

$246 m$235.8 m$216.4 m$334.6 m

Purchases of PP&E

($77.6 m)($60.5 m)($82.9 m)($64.8 m)

Cash From Investing Activities

($86.1 m)($80.4 m)($308.4 m)($90.8 m)

Short-term Borrowings

($1.1 m)($1.4 m)($1.4 m)($1.4 m)

Interest Paid

$5 m$12.3 m$27.2 m

Income Taxes Paid

$67.7 m$60.2 m$54.9 m

IDEXX Laboratories Market Value History

IDEXX Laboratories Job Categories

IDEXX Laboratories Median Salaries

Source: 71 public H-1B filings from IDEXX Laboratories

IDEXX Laboratories Online Presence

IDEXX Laboratories Company Life

You may also be interested in